CN102885296A - 一种用于女性保健的膳食补充剂配方 - Google Patents
一种用于女性保健的膳食补充剂配方 Download PDFInfo
- Publication number
- CN102885296A CN102885296A CN2011102046006A CN201110204600A CN102885296A CN 102885296 A CN102885296 A CN 102885296A CN 2011102046006 A CN2011102046006 A CN 2011102046006A CN 201110204600 A CN201110204600 A CN 201110204600A CN 102885296 A CN102885296 A CN 102885296A
- Authority
- CN
- China
- Prior art keywords
- prescription
- food
- formula
- oviductus ranae
- female health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000036541 health Effects 0.000 title claims description 11
- 235000015872 dietary supplement Nutrition 0.000 title abstract description 6
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 25
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 25
- 210000003101 oviduct Anatomy 0.000 claims abstract description 16
- 235000013305 food Nutrition 0.000 claims abstract description 14
- 239000013589 supplement Substances 0.000 claims abstract description 9
- 230000009758 senescence Effects 0.000 claims abstract 5
- 150000001875 compounds Chemical class 0.000 claims abstract 2
- 108010022355 Fibroins Proteins 0.000 claims description 19
- 102000008186 Collagen Human genes 0.000 claims description 15
- 108010035532 Collagen Proteins 0.000 claims description 15
- 229920001436 collagen Polymers 0.000 claims description 14
- 102000001554 Hemoglobins Human genes 0.000 claims description 12
- 108010054147 Hemoglobins Proteins 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 235000012054 meals Nutrition 0.000 claims description 8
- 230000032683 aging Effects 0.000 claims description 6
- 239000000413 hydrolysate Substances 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 15
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 8
- 229910052742 iron Inorganic materials 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 150000001413 amino acids Chemical class 0.000 abstract description 3
- 239000007901 soft capsule Substances 0.000 abstract description 3
- 208000019901 Anxiety disease Diseases 0.000 abstract description 2
- 230000036506 anxiety Effects 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 17
- 208000007502 anemia Diseases 0.000 description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 7
- 239000003797 essential amino acid Substances 0.000 description 6
- 235000020776 essential amino acid Nutrition 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 4
- 102000018146 globin Human genes 0.000 description 4
- 108060003196 globin Proteins 0.000 description 4
- 230000009245 menopause Effects 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- 239000004471 Glycine Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 230000002611 ovarian Effects 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 235000004213 low-fat Nutrition 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 206010070840 Gastrointestinal tract irritation Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000270940 Rana temporaria Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003035 anti-peroxidant effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229940082629 iron antianemic preparations Drugs 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000003170 nutritional factors Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- -1 porphyrin compound Chemical class 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000000515 tooth Anatomy 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011102046006A CN102885296B (zh) | 2011-07-21 | 2011-07-21 | 一种用于女性保健的膳食补充剂配方 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011102046006A CN102885296B (zh) | 2011-07-21 | 2011-07-21 | 一种用于女性保健的膳食补充剂配方 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102885296A true CN102885296A (zh) | 2013-01-23 |
CN102885296B CN102885296B (zh) | 2013-12-25 |
Family
ID=47529148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011102046006A Active CN102885296B (zh) | 2011-07-21 | 2011-07-21 | 一种用于女性保健的膳食补充剂配方 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102885296B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110169970A (zh) * | 2019-06-28 | 2019-08-27 | 上海康孕企业管理合伙企业(有限合伙) | 血红素在改善更年期的药物、食品及保健食品中的应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1252231A (zh) * | 1999-10-14 | 2000-05-10 | 余国华 | 血红蛋白系列食品及其制造方法 |
CN1348720A (zh) * | 2000-10-13 | 2002-05-15 | 常纪庆 | 中国林蛙油蛋白露 |
JP2003334032A (ja) * | 2002-03-12 | 2003-11-25 | Suehito Yamagami | 睡眠障害の改善作用を有する健康補助食品 |
CN1626235A (zh) * | 2004-08-12 | 2005-06-15 | 唐天德 | 复方蛤士蟆制剂及其制备方法 |
CN1823606A (zh) * | 2006-04-06 | 2006-08-30 | 浙江省农业科学院 | 食用蚕丝蛋白粉及丝精的制备方法 |
CN101120951A (zh) * | 2006-08-10 | 2008-02-13 | 孙欣 | 润巢软胶囊及其制作方法 |
KR20080049332A (ko) * | 2006-11-30 | 2008-06-04 | 김선여 | 미백용 합마유 추출물 |
-
2011
- 2011-07-21 CN CN2011102046006A patent/CN102885296B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1252231A (zh) * | 1999-10-14 | 2000-05-10 | 余国华 | 血红蛋白系列食品及其制造方法 |
CN1348720A (zh) * | 2000-10-13 | 2002-05-15 | 常纪庆 | 中国林蛙油蛋白露 |
JP2003334032A (ja) * | 2002-03-12 | 2003-11-25 | Suehito Yamagami | 睡眠障害の改善作用を有する健康補助食品 |
CN1626235A (zh) * | 2004-08-12 | 2005-06-15 | 唐天德 | 复方蛤士蟆制剂及其制备方法 |
CN1823606A (zh) * | 2006-04-06 | 2006-08-30 | 浙江省农业科学院 | 食用蚕丝蛋白粉及丝精的制备方法 |
CN101120951A (zh) * | 2006-08-10 | 2008-02-13 | 孙欣 | 润巢软胶囊及其制作方法 |
KR20080049332A (ko) * | 2006-11-30 | 2008-06-04 | 김선여 | 미백용 합마유 추출물 |
Non-Patent Citations (1)
Title |
---|
卢长庆: "美颜润肤的药膳", 《中老年保健》, no. 10, 31 December 2004 (2004-12-31), pages 41 - 42 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110169970A (zh) * | 2019-06-28 | 2019-08-27 | 上海康孕企业管理合伙企业(有限合伙) | 血红素在改善更年期的药物、食品及保健食品中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN102885296B (zh) | 2013-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106579375A (zh) | 一种燕窝胶原蛋白肽复合粉及其制备工艺 | |
KR101702851B1 (ko) | 발모촉진, 탈모예방과 모낭개선용 식용귀뚜라미 조성물 | |
CN108991532A (zh) | 一种包含不同来源的胶原蛋白肽的口服美肤剂 | |
GB2268871A (en) | Composition for use as a food or food supplement | |
JP2012171901A (ja) | 男性用の発毛および育毛用経口摂取食品 | |
WO1994001006A2 (en) | Composition for use as a food or food supplement | |
KR20210124113A (ko) | 필러의 효능 유지용 조성물 | |
WO2021133284A1 (en) | A composition of hyaluronic acid and hydrolyzed collagen with vitamins and its production method | |
JPH11332527A (ja) | 燕の巣のエキス製造方法及び燕の巣入り健康食品、 化粧品等 | |
CN101040710A (zh) | 一种内服调节女士内分泌兼外用美容养颜的保健营养冲剂 | |
CN102885296B (zh) | 一种用于女性保健的膳食补充剂配方 | |
CN111110833A (zh) | 一种内服外涂的养颜美容组合物及其制备方法 | |
CN107530367A (zh) | 口腔护理组合物 | |
CN101041069A (zh) | 一种能美容、补血的制剂 | |
JP5997485B2 (ja) | 肌質改善組成物及びその製造方法 | |
CN101869609B (zh) | 一种气血双补药物及其制备方法与应用 | |
CZ37098U1 (cs) | Potravinový doplněk s kolagenem se shatavari a/nebo bezovým květem a/nebo citronem | |
CZ37103U1 (cs) | Potravinový doplněk s kolagenem a bylinnými extrakty, mátou a citronem | |
CN102948663A (zh) | 一种林蛙油颗粒剂及其制备方法 | |
CZ37101U1 (cs) | Potravinový doplněk s kolagenem s jahodou | |
CZ37102U1 (cs) | Potravinový doplněk s kolagenem s příchutí ananasu | |
CN101507488A (zh) | 复合强化营养鸡精 | |
CN106722936A (zh) | 以海洋生物为主要原料的保健品 | |
CN102085242A (zh) | 无花果保健胶囊 | |
CN101757087A (zh) | 一种保健胶囊 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: TIAN XI Effective date: 20131120 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20131120 Address after: 611130 Yongkang Road, Wenjiang District, Sichuan, No. 688, No. Applicant after: Chengdu Yonkon Pharmacy Co.,Ltd. Address before: 611130 Yongkang Road, Wenjiang District, Sichuan, No. 688, No. Applicant before: Chengdu Yonkon Pharmacy Co.,Ltd. Applicant before: Tian Xi |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A dietary supplement formula for women's health Granted publication date: 20131225 Pledgee: Chengdu Bank Co.,Ltd. Wenjiang Branch Pledgor: Chengdu Yonkon Pharmacy Co.,Ltd. Registration number: Y2024980008255 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |